MiR-328-5p/BCL7A轴通过调节骨质母细胞功能参与骨折愈合
1Department of Traditional Chinese Medicine Orthopedics, Jiangsu Province Hospital of Chinese Medicine, The Affiliated Hospital of Nanjing University of Chinese Medicine, No.155, Hanzhong Road, Qinhuai District, Nanjing City, 210000, Jiangsu Province, China.
Journal of orthopaedic surgery and research
|December 19, 2025
概括
微RNA-328-5p (miR-328-5p) 在延迟骨折愈合时受到下调,并通过向BCL7A.A.来损害骨质细胞分化. 这种微RNA显示出作为改善骨折修复的生物标志物和治疗点的潜力.
科学领域:
- 生物医学科学 生物医学科学
- 分子生物学分子生物学
- 整形外科 整形外科 整形外科
背景情况:
- 骨折愈合延迟对患者的生活质量带来了重大挑战,并造成了巨大的经济成本.
- 了解骨折愈合的分子基础对于开发有效的治疗策略至关重要.
研究的目的:
- 研究微RNA-328-5p (miR-328-5p) 在骨折愈合中的作用和分子机制.
- 评估miR-328-5p作为延迟骨折愈合的潜在诊断生物标志物.
主要方法:
- 在125名骨骨折患者中,使用RT-qPCR量化血清miR-328-5p水平.
- 在体外研究评估了miR-328-5p对hFOB 1.19细胞骨质分化,细胞增殖和细胞亡的影响.
- 生物信息学和双露西法酶记者分析确定BCL7A是miR-328-5p的直接目标.
主要成果:
- 在骨折愈合延迟的患者中观察到miR-328-5p的显著下调,这表明诊断潜力.
- 在骨质分化过程中,miR-328-5p的表达增加;其抑制抑制了骨质分化标记物和性酸酶活性.
- 抑制miR-328-5p损害了骨质母细胞增殖和促进了亡,BCL7A被确定为一个关键的媒介.
结论:
- MiR-328-5p作为诊断延迟骨折愈合的有希望的生物标志物.
- MiR-328-5p通过BCL7A调节骨质细胞分化,为增强骨折修复提供潜在的治疗点.
相关概念视频
Fractures: Bone Repair
4.9K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
4.9K
Osteoclasts in Bone Remodeling
3.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.8K
Bone Remodeling
40.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.2K
TGF - β Signaling Pathway
10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K


